Northern Trust Corp Aclaris Therapeutics, Inc. Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 127,225 shares of ACRS stock, worth $485,999. This represents 0.0% of its overall portfolio holdings.

Number of Shares
127,225
Previous 520,469 75.56%
Holding current value
$485,999
Previous $572,000 75.0%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$1.12 - $1.4 $440,433 - $550,541
-393,244 Reduced 75.56%
127,225 $143,000
Q2 2024

Aug 14, 2024
SELL
$1.01 - $1.36 $42,172 - $56,786
-41,755 Reduced 7.43%
520,469 $572,000
Q1 2024

May 14, 2024
SELL
$0.92 - $1.44 $89,619 - $140,274
-97,413 Reduced 14.77%
562,224 $697,000
Q4 2023

Feb 13, 2024
BUY
$0.64 - $6.49 $170 - $1,726
266 Added 0.04%
659,637 $692,000
Q3 2023

Nov 13, 2023
BUY
$6.56 - $10.95 $61,952 - $103,411
9,444 Added 1.45%
659,371 $4.52 Million
Q2 2023

Aug 11, 2023
BUY
$7.89 - $10.64 $670,523 - $904,229
84,984 Added 15.04%
649,927 $6.74 Million
Q1 2023

May 15, 2023
SELL
$7.07 - $17.95 $17,858 - $45,341
-2,526 Reduced 0.45%
564,943 $4.57 Million
Q4 2022

Feb 13, 2023
BUY
$14.33 - $18.37 $200,405 - $256,904
13,985 Added 2.53%
567,469 $8.94 Million
Q3 2022

Nov 14, 2022
BUY
$13.07 - $18.22 $389,551 - $543,047
29,805 Added 5.69%
553,484 $8.71 Million
Q2 2022

Aug 12, 2022
BUY
$10.16 - $17.08 $543,692 - $914,002
53,513 Added 11.38%
523,679 $7.31 Million
Q1 2022

May 13, 2022
SELL
$9.74 - $17.92 $191,196 - $351,769
-19,630 Reduced 4.01%
470,166 $8.11 Million
Q4 2021

Feb 08, 2022
SELL
$12.27 - $18.49 $145,239 - $218,866
-11,837 Reduced 2.36%
489,796 $7.12 Million
Q3 2021

Nov 15, 2021
BUY
$13.38 - $18.8 $604,735 - $849,703
45,197 Added 9.9%
501,633 $9.03 Million
Q2 2021

Aug 13, 2021
BUY
$17.08 - $29.6 $5.94 Million - $10.3 Million
347,641 Added 319.54%
456,436 $8.02 Million
Q1 2021

May 12, 2021
BUY
$5.86 - $27.73 $106,112 - $502,134
18,108 Added 19.97%
108,795 $2.74 Million
Q4 2020

Feb 11, 2021
SELL
$2.65 - $7.61 $13,501 - $38,772
-5,095 Reduced 5.32%
90,687 $586,000
Q3 2020

Nov 16, 2020
SELL
$1.5 - $2.71 $4,236 - $7,653
-2,824 Reduced 2.86%
95,782 $247,000
Q2 2020

Aug 14, 2020
SELL
$1.04 - $1.73 $266,781 - $443,781
-256,521 Reduced 72.23%
98,606 $160,000
Q1 2020

May 14, 2020
BUY
$0.75 - $2.18 $8,456 - $24,579
11,275 Added 3.28%
355,127 $370,000
Q4 2019

Feb 14, 2020
SELL
$1.02 - $1.97 $35,130 - $67,850
-34,442 Reduced 9.1%
343,852 $650,000
Q3 2019

Nov 13, 2019
SELL
$0.79 - $2.47 $42,002 - $131,324
-53,168 Reduced 12.32%
378,294 $409,000
Q2 2019

Aug 13, 2019
SELL
$2.13 - $7.06 $8,773 - $29,080
-4,119 Reduced 0.95%
431,462 $945,000
Q1 2019

May 13, 2019
SELL
$5.63 - $7.84 $52,702 - $73,390
-9,361 Reduced 2.1%
435,581 $2.61 Million
Q4 2018

Feb 12, 2019
BUY
$6.3 - $15.4 $571,983 - $1.4 Million
90,791 Added 25.64%
444,942 $3.29 Million
Q3 2018

Nov 14, 2018
BUY
$14.38 - $20.89 $850,116 - $1.23 Million
59,118 Added 20.04%
354,151 $5.14 Million
Q2 2018

Sep 18, 2018
SELL
$16.46 - $20.33 $32,755 - $40,456
-1,990 Reduced 0.67%
295,033 $5.89 Million
Q2 2018

Aug 14, 2018
BUY
$16.46 - $20.33 $23,899 - $29,519
1,452 Added 0.49%
297,023 $5.93 Million
Q1 2018

May 09, 2018
BUY
$17.08 - $25.64 $69,139 - $103,790
4,048 Added 1.39%
295,571 $5.18 Million
Q4 2017

Feb 14, 2018
SELL
$21.47 - $27.8 $37,271 - $48,260
-1,736 Reduced 0.59%
291,523 $7.19 Million
Q3 2017

Nov 13, 2017
BUY
$23.02 - $28.8 $6.75 Million - $8.45 Million
293,259
293,259 $7.57 Million

Others Institutions Holding ACRS

# of Institutions
84
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $255M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email